Berry Consultants will again have a strong presence at this year’s ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop in Washington, D.C. on September 12-14, 2018. Team members presenting are Scott Berry, Melanie Quintana and Tom Parke. Scott Berry will be a part of the Friday, September 14th Parallel Session from 1:15 to 2:30pm, “Adaptive Enrichment Designs: New Methods and Clinical Applications”, where he will discuss the Bayesian adaptive DAWN stroke trial.
Melanie Quintana will be a part of the Friday, September 14th Parallel Session from 1:15 to 2:30 pm, “Innovations in Rare Disease Clinical Programs” where she will discuss Combining Clinical Progression Modeling with Innovative Trial Design in Rare Disease Trials. Tom Parke will present the topic, “Evaluating Phase II Trial Designs by Estimating the Effect on the Net Present Value of the Development Program” during a Roundtable Discussion from 11:45am to 1:15pm on Thursday, September, 13. To learn more and register to attend the event, please visit the workshop web page.